welcome to cyprotex

News

April 2, 2009 - Cyprotex Launches its New Website

Cyprotex today launches its new website, www.cyprotex.com.

Cyprotex realise the importance of maintaining an easy-to-use and informative site which keeps our customers and investors up-to-date with current developments. As well as our product catalogue, our educational guide titled ‘Everything you Need to Know about ADME but were too Afraid to Ask’ is also available from our website. Both provide useful resources for learning more about ADME and pharmacokinetics and how data are used in a drug discovery and development setting. Our news and events section assists in familiarising our customers or investors with any new developments at Cyprotex. A separate IR section within the website is dedicated to providing critical information to our investors.

One exciting addition to the website will be the launch of Cloe® Gateway our new web portal which allows access to online drug discovery services. This will be available very shortly and will open up a number of interactive tools online.

Commenting on the launch of the website, Dr Anthony D Baxter, Cyprotex's Chief Executive Officer, said:

“Our website is an important source of information for our customers. We are looking forward to expanding our range of web-based resources and this will include the introduction of Cloe® Gateway our exciting new web portal which allows access to online services. The requirement for web-based services is growing. Cyprotex very much see this as the future of drug discovery service provision and are well placed to meet this need.’

For further information:

Cyprotex PLC

Helen Gill PhD, Product Development Manager
Tel: +44 (0)1625 505 100
h.gill@cyprotex.com
www.cyprotex.com

view all the latest news +
2009 archive +
2008 archive +
2007 archive +
2006 archive +
2005 archive +
2004 archive +
2003 archive +
2002 archive +
contact

Contact us for more information on Cyprotex Discovery, including our extensive range of ADMET/PK services
and pricing.

contact
careerscontactlegalprivacy
This website was last updated
on 8th September 2010
This website is intended to assist investors, industry participants, customers and employees to understand Cyprotex’s global operations and ambitions.
Certain information and detail is disclosed in the interest of compliance of AIM Rule 26.